Medical illustration of a fenestrated endovascular aortic repair (fEVAR), showing a stent graft in the abdominal aorta with branch stents extending into both renal arteries and additional branch vessels.
The first and only FDA-approved bridging stent graft for both fenestrated and branched endovascular repairs

The bridging stent graft that supports your expertise in complex visceral repair.1-3 Learn more about the VBX Stent Graft for FEVAR and BEVAR.

Explore the new FEVAR and BEVAR indication
VSX icon-red

Designed to deliver. Proven to perform.

Built to expand to clinical demands, the VBX Stent Graft offers proven procedural successa and long-term outcomes4-6 with flexibility, strength, and accuracy to treat aortoiliac occlusive disease (AIOD) and thoracoabdominal aneurysmal disease.

Four GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) devices of increasing lengths arranged horizontally on a white background.
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) curled and overlapping to demonstrate its flexibility.
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) mounted on a balloon delivery catheter and shown horizontally on a white background.
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) shown at an angle with a wider open end on a white background.
Flexibility, strength, and accuracy in your hands
See how the VBX Stent Graft deploys and navigates anatomy with flexibility and ease.
    VSX icon-red

    A closer look at the VBX Stent Graft specifications

    The VBX Stent Graft comes in lower profile options with a 1 Fr reduction for most sizes, completing the broadest offering of balloon expandable stent graft diameters and lengths on the market.1-3,7

    Review device specifications
      Complete portfolio with lower profile sizes
      Watch as Darren Schneider, MD; Andrew Holden, MD; William Gray, MD; and Venita Chandra, MD, discuss the benefits of the reduced-profile VBX Stent Graft.

      Anytime we can reduce profile without sacrificing performance, that improves the safety of a procedure.

      Darren Schneider, MD

      Headshot of Darren Schneider
      VSX icon-red

      The difference is in our data

      The VBX Stent Graft has delivered reliable procedurala and clinical performance, with trusted patency and patient benefit — supported by independently validated clinical evidence.

      EMBRACE Registry

      Target vessel technical successa
      FEVAR 100%8
      BEVAR 99.6%9

      VBX FLEX 5-year outcomes

      100% of patients improved ≥ 1 Rutherford category from baseline6

      check-white

      Complex aortic repair: Gore EMBRACE Clinical Study and Gore EXPAND Clinical Study

      The VBX Stent Graft has been extensively studied in hundreds of FEVAR and BEVAR procedures in real-world patients, in the Gore EMBRACE and EXPAND Registries, and in multiple publications.

      VBX FLEX 5-year outcomes

      90% primary patency per lesion in AIOD6

      review-data-black

      The VBX Stent Graft demonstrated long-term, durable clinical outcomes in complex AIOD treatment through 5 years.6

      Explore the data
      See all case studies

      Related to this product

      a. Based on previously collected clinical data. Evaluation of the reduced-profile delivery system is ongoing.

      1. W. L. Gore & Associates. GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Instructions for Use. 2026. MD169334, Rev. 9; MD208864, Rev. 3.
      2. Instructions for Use. Bard Peripheral Vascular; 2019. BAW1345700, Rev 5.
      3. Atrium Medical Corporation. iCAST Covered Stent System Instructions for Use. Atrium Medical Corporation; 2023. AW009603-EN, Rev 11.
      4. Panneton JM, Bismuth J, Gray BH, Holden A. Three-year follow-up of patients with iliac occlusive disease treated with the VIABAHN Balloon-Expandable Endoprosthesis. J Endovasc Ther. 2020;27(5):728-736. doi:10.1177/1526602820920569 
      5. Bismuth J, Gray BH, Holden A, Metzger C, Panneton J; VBX FLEX Study Investigators. Pivotal study of a next-generation balloon-expandable stent-graft for treatment of iliac occlusive disease. J Endovasc Ther. 2017;24(5):629-637. doi:10.1177/1526602817720463. OPEN ACCESS http://journals.sagepub.com/doi/full/10.1177/1526602817720463
      6. Holden A, Takele E, Hill A, et al. Long-term follow-up of subjects with iliac occlusive disease treated with the VIABAHN VBX Balloon-Expandable Endoprosthesis. J Endovasc Ther. 2025;32(1):68-76. doi:10.1177/15266028231165723 
      7. Bard Peripheral Vascular. LIFESTREAM® Balloon Expandable Vascular Covered Stent 
      8. Data on file. W. L. Gore & Associates; 2025. VBX 21-04 EMBRACE registry 1-year FEVAR data for publications and presentations.
      9. Data on file. W. L. Gore & Associates; 2025. VBX 21-04 EMBRACE registry 1-year BEVAR data for publications and presentations.
      IFU Consult instructions

      Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

      INDICATIONS FOR USE IN THE US: The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is indicated for the treatment of de novo or restenotic lesions found in iliac arteries with reference vessel diameters ranging from 5 mm - 13 mm and lesion lengths up to 110 mm, including lesions at the aortic bifurcation.

      The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is indicated to maintain visceral artery perfusion as a bridging stent in:

      • fenestrated endovascular aortic aneurysm repair with 6-8 mm diameter fenestrations
      • branched endovascular aortic aneurysm repair with 6-8 mm diameter branches (e.g. portals, cuffs, or directional branches) that are at least 10 mm in length.

      Bridging stent use is limited to aortic endovascular graft systems wherein safety and effectiveness has been demonstrated.   

      CONTRAINDICATIONS: Do not use the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis in patients with known hypersensitivity to heparin, including those patients who have had a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II. Patients with known sensitivities or allergies to the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis materials including expanded polytetrafluoroethylene (ePTFE), fluorinated ethylene propylene (FEP), stainless steel, and heparin.

      The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is not authorized for use with thoracoabdominal and pararenal branched devices indicated with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis as a branch component in Canada.

      24PL1105-EN04 MAT-0848-1